| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 96420-72-3 | 解草烷; 2-二氯甲基o-甲基-1,3-二恶茂烷 | mg 191; 2-dichloromethyl-2-methyL-1,3-dioxolane | ![]() | C5H8Cl2O2 | 详情 | 供应商 |
| 148274-76-4 | 2-Pyrrolidinone,1-[2-hydroxy-3-(4-phenyL-1-piperazinyl)propyl]-; mg 1 | ![]() | C17H25N3O2 | 详情 | 供应商 | |
| 63968-75-2 | INDAPAMIDE RELATED COMPOUND A (50 mg) (4-CHLORO-N-(2-METHYL-INDOL-1-YL)-3-SULFAMOYLBEN-ZAMIDE) (AS); INDAPAMIDE RELATED COMPOUND A (50 mg) (4-CHLORO-N-(2-METHYL-INDOL-1-YL)-3-SULFAMOYLBEN-ZAMIDE) (AS); 3-(aminosulfonyl)-4-chloro-n-(2-methyL-1h-indoL-1-yl)-benzamid; 4-chloro-n-(2-methyL-1-indolyl)-3-sulfamoyl-benzamid; 4-chloro-n-(2-methyL-1-indolyl)-3-sulfamoylbenzamide; Dehydro Indapamide | ![]() | C16H14ClN3O3S | 详情 | 供应商 | |
| 107362-12-9 | 瑞格列奈相关物质C; 瑞格列奈相关物质C | REPAGLINIDE RELATED COMPOUND C (25 mg) ((S)-2-ETHOXY-4-[2-[[2-PHENYL-1 -[2-(1 -PIPERIDINYL)PHE-NYL]E; REPAGLINIDE RELATED COMPOUND C (25 mg) ((S)-2-ETHOXY-4-[2-[[2-PHENYL-1 -[2-(1 -PIPERIDINYL)PHE-NYL]ETHYL]AMINO]-2-OXOETHYL] BENZOIC ACID); Repaglinide Related Compound C (25 mg) ((S)-2-Ethoxy-4-[2-[[2-phenyL-1-[2-(1-piperidinyl)phenyl]ethyl]amino]-2-oxoethyl] benzoic acid); (S)-2-Ethoxy-4-[2-[[2-phenyL-1-[2-(1-piperidinyl)phenyl]ethyl]aMino]-2-oxoethyl] benzoic acid; Repaglinide Related CoMpound C; 2-Desisopropyl-2-phenyl Repaglinide (Repaglinide IMpurity) | 无 | C30H34N2O4 | 详情 | 供应商 |
| 109518-50-5 | 依托度酸相关化合物A; 依托度酸相关化合物A; 依托度酸杂质A | ETODOLAC RELATED COMPOUND A (25 mg) ((+/-)-8-ETHYL-1-METHYL-1,3,4,9-TETRAHYDROPYRANO [3,4-B]-INDOLE-; ETODOLAC RELATED COMPOUND A (25 mg) ((+/-)-8-ETHYL-1-METHYL-1,3,4,9-TETRAHYDROPYRANO [3,4-B]-INDOLE-1-ACETIC ACID); Etodolac Related Compound A (25 mg) ((+/-)-8-ethyL-1-methyL-1,3,4,9-tetrahydropyrano [3,4-b]-indole-1-aceticacid) | 无 | 详情 | 供应商 | |
| 177472-30-9 | Levofloxacin Related Compound C (25 mg) ((S)-ethyl 9-fluoro-2,3-dihydro-3-methyL-10-(4-methyL-1-pipe | 无 | 详情 | 供应商 | ||
| 865792-18-3 | Cilostazol Related Compound C (50 mg) (1-(4-(5-CyclohexyL-1H-tetrazoL-1-yl)butyl)-6-(4-(1-cyclohexyl | 无 | 详情 | 供应商 | ||
| 1026353-20-7 | Telmisartan Related Compound B (15 mg) (4'-[(1,7'-dimethyl-2'-propyL-1H,1'H-2,5'-bibenzo[d]imidazol-; Telmisartan Related Compound B (15 mg) (4'-[(1,7'-dimethyl-2'-propyL-1H,1'H-2,5'-bibenzo[d]imidazoL-1'-yl)methyl]biphenyl-2-carboxylic acid); 4'-[(1,7'-DiMethyl-2'-propyl[2,5'-bi-1H-benziMidazol]-1'-yl)Methyl][1,1'-biphenyl]-2-carboxylic Acid; 4'-DesMethyl-7'-Methyl TelMisartan; TelMisartan EP IMpurity B | 无 | 详情 | 供应商 | ||
| 39925-19-4 | Ribavirin Related Compound A (15 mg) (1-beta-D-ribofuranosyL-1H-1,2,4-triazole-3-carboxylic acid); Ribavirin Related Compound A (15 mg) (1-beta-D-ribofuranosyL-1H-1,2,4-triazole-3-carboxylic acid); 1-β-D-Ribofuranosyl- 1,2,4-triazole-3-carboxylic Acid; 1-β-D-RibofuranosyL-1H-1,2,4-triazole-3-carboxylic Acid; Ribavirin Carboxylic Acid; Ribavirin IMpurity A | 无 | 详情 | 供应商 |